ivWatch Patient Monitoring System

ivWatch continuously monitors tissue adjacent to IV insertion sites,
providing early detection of infiltration/extravasation events using
proprietary monitors and sensors to reduce patient injury. In March, we
received FDA clearance to detect iron sucrose extravasations, the
leakage outside veins, which causes permanent irreversible skin
staining.

EluPro™

EluPro is the world’s first FDA cleared antibiotic-eluting BioEnvelope
that resolves common post-surgical device failures. It consists of a
natural biomaterial to stabilize medical devices and incorporates
rifampin and minocycline, which reduces the risk of bacterial
complications and addresses critical surgical complications.

Dual-Phase Hydrogel

Dual-Phase Hydrogel is a groundbreaking liquid biomaterial that becomes
gelatinous at body temperature. Administered via injection without open
surgery required, it prevents post-surgical adhesions and stimulates
cell growth to speed up recovery. This innovation is perfect for
treating lumbar laminectomy, knee osteoarthritis, and bone fracture.

Ready for Nomination Season?

Complete the form below to download the 2027 Nomination Guide.

A Founders Guide to Modern Innovation
The Future of the Grid – Panel Discussion 2024 Edison Awards
Edison Award-Winning Brain Technology Featured in U.S. News & World Report